ROCHE HLDG LTD SPONS Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (26)

Latest Posts

About This Stock More About This Stock
E Bull In A China Bourse
Article By: Vivian Lewis
Saturday, June 24, 2017 2:16 PM EDT
It has become standard here in Britain to favor the FTSE 100 over broader UK indexes, because of its multinational company focus. Broader UK indexes depend on consumer spending which is down sharply.
In this article: AGU, ALV, BCS, CAE, CPA, CX, GSK, MXE, NOK, NVO, POT, SLB, SAN, DGRLY, DNACF, MXCHF, NPSNY, NTDOY, OROCF, RHHBY, SLFPY, TCTZF, INFY, SHPG, TEVA, RBGLY, FBASF, VRGDF
Read
Rayno Life Science Portfolio 2017
Article By: Rod Raynovich
Saturday, June 17, 2017 11:22 AM EDT
Let's review Rayno Life Science Portfolio for 2017.
In this article: BMY, RHHBY, IBB, QQQ, AMGN, GILD, HOLX, XBI, ABBV, BLUE, FMI
Read
ASCO Update: Movers On The News - INCY, PBYI, RHHBY
Article By: Rod Raynovich
Tuesday, June 6, 2017 2:00 AM EDT
A lot of the product news is already “baked into” stock prices but here is a brief summary of big movers on clinical news updates. The bellwether XBI peaked at $71.72 yesterday and is down 0.62% to $70.66.
In this article: BMY, RHHBY, INCY, XBI, PUMA, BLUE
Read
5 Drug Stocks In Focus On World MS Day
Article By: Arpita Dutt
Wednesday, May 31, 2017 11:23 AM EDT
The multiple sclerosis market represents huge commercial potential. Here are some of the key players in the MS market.
In this article: BIIB, TEVA, NVS, SNY, RHHBY
Read
Conatus Pharmaceuticals Launches Small Offering For Pipeline Expansion
Article By: Terry Chrisomalis
Friday, May 12, 2017 7:05 PM EDT
The offering doesn’t seem to make sense after the Novartis (NVS) licensing deal being signed.
In this article: CNAT, NVS, RHHBY
Read

PARTNER HEADLINES

Latest Tweets for $RHHBY

No tweets yet!